Skip to content

Effects of the formula of lowering the rebelliousness and promoting the internal organs on oesophageal SP and CGRP in NERD patients with highsensitivity of oesophageal viscera and spleen stomach dampness heat type.

Effects of the formula of lowering the rebelliousness and promoting the internal organs on oesophageal SP and CGRP in NERD patients with highsensitivity of oesophageal viscera and spleen stomach dampness heat type.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000396
Enrollment
Unknown
Registered
2025-02-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-erosive reflux disease

Interventions

Group treated with the formula of Reducing Reversal and Promoting Viscera placebo:Treating with the formula of Reducing Reversal and Promoting Viscera placebo
Group treated with the formula of Reducing Reversal and Promoting Viscera :Treating with the formula of Reducing Reversal and Promoting Viscera

Sponsors

The Affiliated Hospital of Shanxi University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with nerdThe ages of between 18 and 75Chinese medicine diagnosed as spleen stomach dampness heat type 2.Negative diagnosis by endoscopyNot taking acid-suppressant 3.No abnormal esophageal resting pressureexcept for esophageal dyskinesia 4.Positive esophageal acid perfusion test acid perception hypersensitivity or reduced perception threshold for mechanical dilatation stimuli.

Exclusion criteria

Exclusion criteria: 1. Patients with serious primary diseases of the cardiovascular cerebrovascular hepatic renal endocrine hematopoietic systems and psychiatric disorders. 2. Tumors of the digestive tract; peptic ulcer; diseases of the liver gallbladder and pancreas cholecystectomy diabetes mellitus connective tissue diseases and other systemic diseases. 3. Women who are pregnant or breastfeeding; 4. People with allergies or multiple drug sensitivities; 5. Those with other digestive disorders other systemic diseases that can cause gastrointestinal symptoms such as irritable bowel syndrome (IBS); 6. Less than 20 years of age and more than 75 years of age.

Design outcomes

Primary

MeasureTime frame
Number of substance P\calcitonin gene related peptide positive nerve fibers;Ultrastructural changes in synaptic vesicles of nerve fibers ;Average optical density value;

Secondary

MeasureTime frame
Assessment of the efficacy of clinical symptoms in Chinese medicine;Typical symptoms such as acid reflux heartburn post-chest pain and discomfort belching reflux etc.;

Countries

China

Contacts

Public ContactPeifang Li

The Affiliated Hospital of Shanxi University of Chinese Medicine

fangfang444@163.com15235181143

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026